F&P accuses ResMed of stealing ideas, its rival does the same – and tries to stop export and sale of F&P's products.
Calida Smylie Thu, 18 Aug 2016
Two days after Fisher & Paykel Healthcare [NZX:FPH] filed patent infringement proceedings against New York stock exchange-listed ResMed [NYSE:RMD], the rival has turned around and accused F&P of the same thing.
On Tuesday, F&P filed proceedings in the US District Court for the Central District of
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).